Eisai Co., Ltd. and Biogen Inc. announced that the FDA has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection (brand name: Leqembi IQLIK)… read more.
Takeda China announced that the National Medical Products Administration (NMPA) of China has approved the use of Orzeyful (oveporexton) for the treatment of narcolepsy type 1 (NT1) in… read more.
A hospital’s overall experience with general anesthesia (GA) or conscious sedation (CS) may influence how anesthesia choice affects patient outcomes during mechanical thrombectomy, according to research presented at… read more.
Pfizer Japan Inc. and Eisai Co., Ltd. announced that the companies will commence the co-promotion of the oral calcitonin gene-related peptide (CGRP) receptor antagonist Nurtec OD Tablet 75mg… read more.
While more women globally are using medication to have abortions, a University of Maryland-led study out today in JAMA Psychiatry found no evidence that a first medication or procedural abortion… read more.
An international research team led by the Medical University of Vienna has investigated a new peptide derived from cone snail venom which significantly reduced inflammation-induced pain in an… read more.
When schools closed in the spring of 2020 at the onset of the COVID-19 pandemic, the number of children and adolescents receiving mental health treatment in the United… read more.
The over-the-counter approval of naloxone has not translated into equal access across the United States, according to a new cross-sectional study published in JAMA Network Open. Researchers conducting… read more.
NICE (UK): Atogepant can be used as an option for the acute treatment of migraine with or without aura in adults, only if, for previous migraines: i) at… read more.
Social prescribing, in which people are connected with arts and exercise activities and other sources of support, may help adolescents waiting for specialist mental health services by improving… read more.
Misuse of stimulant medications for attention deficit hyperactivity disorder (ADHD) has declined sharply. In 2023, approximately 3.7% of adults under age 30 misused these medications, down from 7.5%… read more.
People diagnosed with early-onset dementia had reduced work productivity up to 15 years before diagnosis, according to a study published July 8, 2026, in Neurology®, the medical journal of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
